Advancing the current state of gene therapies using adeno-associated virus vectors to treat atrial cardiomyopathy.

INTRODUCTION: Atrial cardiomyopathy (ACM) is characterized by complex interactions involving molecular, electrical, and structural abnormalities that predispose individuals to cardiac dysfunction and stroke. Current treatments are effective at managi…

Preview only. Read the full abstract at the source